Social Behavior: Clinical Trials

5 trials for Social Behavior, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 terminated. 5 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 45Terminated 5

Follow Social Behavior: new trials by email Literature Review of Social Behavior trials Research Report on Social Behavior

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR
Twice-daily Tacrolimus, Once-daily envarsus XR, Induction Immunosuppression with Basiliximab or Rabbit Anti Thymoglobulin (rATG) - Kidney Transplantation, Kidney Transplant Rejection
Phase 4TerminatedUniversity of Southern California202021-11-232025-11-10
Effects on Social and Cognition Functions of Blonanserin in First Episode Schizophrenia Patients
Blonanserin, MRI and serum BDNF - First Episode Schizophrenia, Social Function
Phase 4TerminatedMarubeni Pharmaceuticals (Suzhou) Co., Ltd.1022019-01-222024-04-19
Study to Compare hFSH-HP (Fostipur) and hMG-HP(Meriofert) in Patients With Polycystic Ovary Under a IVF/ICSI Cycle.
hMG-HP, hFSH-HP - Polycystic Ovary Syndrome
Phase 4TerminatedFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau192017-02-232019-02-25
Methylphenidate vs. Risperidone for the Treatment of Children and Adolescents With ADHD and Disruptive Disorders
Methylphenidate, Risperidone - Attention Deficit/Hyperactivity Disorder, Oppositional Defiant Disorder
Phase 4TerminatedSheba Medical Center52017-02-012020-03-18
A Trial of Two Steroid-Free Approaches Toward Mycophenolate Mofetil-Based Monotherapy Immunosuppression
Tacrolimus (TAC), Sirolimus, Alemtuzumab - Kidney Transplant Failure and Rejection
Phase 4TerminatedNorthwestern University402005-04-012015-10-26

Narrower conditions

Rejection, Psychology (2)  ·  Aggression (1)  ·  Attention Deficit Disorder with Hyperactivity (1)  ·  Conduct Disorder (1)  ·  Helping Behavior (1)  ·  Oppositional Defiant Disorder (1)  ·  Polycystic Ovary Syndrome (1)  ·  Social Adjustment (1)

Broader conditions

Behavior (5)  ·  Aberrant Motor Behavior in Dementia (1)  ·  Adnexal Diseases (1)  ·  Attention Deficit and Disruptive Behavior Disorders (1)  ·  Behavioral Symptoms (1)  ·  Cysts (1)  ·  Endocrine System Diseases (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Genital Diseases (1)  ·  Genital Diseases, Female (1)  ·  Gonadal Disorders (1)  ·  Mental Disorders (1)  ·  Neoplasms (1)

Interventions

Mycophenolic Acid (2)  ·  Alemtuzumab (1)  ·  Azathioprine (1)  ·  Basiliximab (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Methylphenidate (1)  ·  Methylprednisolone (1)  ·  Prednisone (1)  ·  Risperidone (1)  ·  Sirolimus (1)  ·  Steroids (1)  ·  Tacrolimus (1)  ·  blonanserin (1)

Sponsors

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (1)  ·  Marubeni Pharmaceuticals (Suzhou) Co., Ltd. (1)  ·  Northwestern University (1)  ·  Sheba Medical Center (1)  ·  University of Southern California (1)

Countries

United States (2)  ·  China (1)  ·  Israel (1)  ·  Spain (1)

Top investigators

Doron Gothelf, professor (1)  ·  Joseph R Leventhal, MD, PhD (1)  ·  Juan J Espinos, MD (1)  ·  Santhi Voora, MD (1)  ·  Xin Yu, MD (1)

Results publications

PMID 35443947